Treatment modalities for breast cancer the leading cause of cancer-related deaths in women worldwide include surgery radiotherapy adjuvant chemotherapy targeted therapy and hormonal therapy. The advancement in medical technology has facilitated substantial reduction in breast cancer mortality. However patients may experience cognitive impairment after chemotherapy. This phenomenon called chemotherapy-induced cognitive impairment i.e. "chemobrain" is common among breast cancer survivors. However cognitive function deficits may exist before chemotherapy initiation. This study examined the functional network alterations in breast survivors by using resting-state functional magnetic resonance imaging fMRI. Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.